Improving preclinical modelling to translate drugs to the clinic is one of the key priorities in immunotherapy and immuno-oncology today. We sat down with senior representatives from GemPharmatech and MiNA Therapeutics to find out how best to develop the next generation of preclinical modelling.
T cells can develop an exhausted phenotype as a result of prolonged antigen stimulation.
13 October 2021
Translational & Preclinical Development
Search by Keyword
Filter by Subject Area
Filter by Content Type
We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.